When you have a bunch of 230 kV transmission lines running over your property, why not use them for some scientific experiments? This is where the [Double M Innovations] YouTube channel comes into ...

Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy for breast cancer, regardless of a patient's ESR1 mutation status. Top-line ...